The potential of PARP inhibitors in genetic breast and ovarian cancers. | Ann N Y Acad Sci;1138: 136-45, 2008 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The potential of PARP inhibitors in genetic breast and ovarian cancers.

Drew, Yvette; Calvert, Hilary.

Affiliation

Drew Y; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom. Yvette.drew@ncl.ac.uk

Ann N Y Acad Sci ; 1138: 136-45, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18837894

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Genetic Predisposition to Disease / Enzyme Inhibitors / Poly(ADP-ribose) Polymerase Inhibitors Limits: Female / Humans Language: En Journal: Ann N Y Acad Sci Year: 2008 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Genetic Predisposition to Disease / Enzyme Inhibitors / Poly(ADP-ribose) Polymerase Inhibitors Limits: Female / Humans Language: En Journal: Ann N Y Acad Sci Year: 2008 Document type: Article Affiliation country: Country of publication: